Indefinite Delivery Contract 36E79720D0006
Award Date
2/26/20
Last Date to Order
2/25/25
Federal Agency
National Acquisition Center
Awardee
Amgen USA Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Amgen USA Inc. for the provision of Calcitonin Gene-Related Peptide (CGRP) agents. The single-award contract has a ceiling value of $100,527,333.60 and a period of performance from February 26, 2025, to February 25, 2026, with four one-year option periods.
The contract aims to provide an uninterrupted source of supply for CGRP products to the VA, including its...
The provided information summarizes a federal contract indefinite delivery vehicle (IDV) awarded by the U.S. Department of Veterans Affairs (VA) to Amgen USA Inc., a division of the leading biotechnology company Amgen Inc. The contract, a Federal Supply Schedule (FSS) under the GSA Pharmaceuticals and Drugs (FSS-61-IB) schedule, has a ceiling value of $3.37 billion and allows Amgen to supply pharmaceuticals, drugs, and hematology-related products to various federal agencies.
Specifically, the...
This federal contract IDV award is for the supply of ranibizumab ophthalmic injections to the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The single-award indefinite delivery contract, valued at $11,392,063.40, was issued by the VA National Acquisition Center to the prime contractor Biogen U.S. Corporation, a for-profit pharmaceutical manufacturer. The contract has a performance period from December 23, 2023, through December 22, 2025, with...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Biogen U.S. Corporation, a pharmaceutical and biotechnology company. The contract is under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule, with a ceiling value of $2,210,000,000 and a period of performance through September 2026.
Biogen has been awarded multiple firm-fixed-price delivery orders against this FSS contract for the supply of specialized...
The federal contract IDV is a single-award Indefinite Delivery Contract (IDC) awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars. The contract, valued at a ceiling of $26,399,360.75, is for the supply of pegfilgrastim injectables to the VA, Bureau of Prisons, and Indian Health Service.
The contract has a base period of one year and four one-year option periods, with an estimated annual...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Alvogen, Inc., a for-profit manufacturer of pharmaceutical and healthcare products. The contract, valued at $32,885,990.00, is for the provision of pharmaceuticals, drugs, and hematology-related products (FSS-61-IB) to the VA and other federal agencies.
The contract has an ultimate completion date of September 1, 2025 and was originally awarded on April 15, 2017. It...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract was awarded to Amarin Pharma, Inc., a for-profit organization, with a period of performance from September 1, 2024 to August 31, 2029. The contract has a ceiling value of $1,844,760.00 and covers the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS contract...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) for pharmaceutical and medical products. The prime contractor is AstraZeneca Pharmaceuticals LP, a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $11,746,924,720 and runs from September 30, 2019 to September 30, 2025.
Under this IDV, AstraZeneca has been awarded multiple task orders to provide vaccines, therapeutics, and other...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods.
The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded to Array Biopharma Inc. by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs. The contract has a ceiling value of $3,309,320.00 and a period of performance through June 30, 2024.
The contract provides for the delivery of pharmaceuticals, drugs, and hematology-related products to support the healthcare needs of...